These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12446956)

  • 1. Genetic alterations in presumptive precursor lesions of breast carcinomas.
    Aubele M; Werner M; Höfler H
    Anal Cell Pathol; 2002; 24(2-3):69-76. PubMed ID: 12446956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.
    Coene ED; Schelfhout V; Winkler RA; Schelfhout AM; Van Roy N; Grooteclaes M; Speleman F; De Potter CR
    Virchows Arch; 1997 May; 430(5):365-72. PubMed ID: 9174626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast.
    Werner M; Mattis A; Aubele M; Cummings M; Zitzelsberger H; Hutzler P; Höfler H
    Virchows Arch; 1999 Nov; 435(5):469-72. PubMed ID: 10592049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
    O'Connell P; Pekkel V; Fuqua SA; Osborne CK; Clark GM; Allred DC
    J Natl Cancer Inst; 1998 May; 90(9):697-703. PubMed ID: 9586667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.
    Aubele M; Cummings M; Walsch A; Zitzelsberger H; Nährig J; Höfler H; Werner M
    Anal Cell Pathol; 2000; 20(1):17-24. PubMed ID: 11007434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: relation to morphology, cell proliferation and expression of breast cancer-related genes.
    Fiche M; Avet-Loiseau H; Maugard CM; Sagan C; Heymann MF; Leblanc M; Classe JM; Fumoleau P; Dravet F; Mahé M; Dutrillaux B
    Int J Cancer; 2000 Sep; 89(5):403-10. PubMed ID: 11008201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast.
    Eren F; Calay Z; Durak H; Eren B; Comunoğlu N; Aydin O
    Bosn J Basic Med Sci; 2012 Feb; 12(1):41-50. PubMed ID: 22364303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CHK1 and CCND1 gene copy number changes in breast cancer with dual-colour fluorescence in-situ hybridization.
    Mu K; Li L; Yang Q; Zhang T; Gao P; Meng B; Liu Z; Wang Y; Zhou G
    Histopathology; 2011 Mar; 58(4):601-7. PubMed ID: 21401699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast.
    Lininger RA; Park WS; Man YG; Pham T; MacGrogan G; Zhuang Z; Tavassoli FA
    Hum Pathol; 1998 Oct; 29(10):1113-8. PubMed ID: 9781650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions.
    Reis-Filho JS; Lakhani SR
    Breast Cancer Res; 2003; 5(6):313-9. PubMed ID: 14580249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
    Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
    Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
    Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M
    Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
    Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.